Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test
Filed with ASX · · 2 pages · English
Earlier from Inoviq
- BARD1 lodges spp and options prospectus
- BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
- Updated Investor Presentation
- BARD1 $15m Placement to Accelerate Cancer Diagnostic Program
- BARD1 Investor Presentation
Later from Inoviq
- BARD1 Share Purchase Plan Completed Oversubscribed
- BARD1 Appoints New CSO
- AGM Presentation
- Appendix 4C & Quarterly Activities Report
- Brazilian Patent Issued for Lung & Colorectal Cancer
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq